These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12511611)

  • 21. Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.
    Yoshikawa N; Nagasaki M; Sano M; Tokudome S; Ueno K; Shimizu N; Imoto S; Miyano S; Suematsu M; Fukuda K; Morimoto C; Tanaka H
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1363-73. PubMed ID: 19293335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding Site.
    Luz JG; Carson MW; Condon B; Clawson D; Pustilnik A; Kohlman DT; Barr RJ; Bean JS; Dill MJ; Sindelar DK; Maletic M; Coghlan MJ
    J Med Chem; 2015 Aug; 58(16):6607-18. PubMed ID: 26218343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid versus antiglucocorticoid activity: can a single functional group modification of glucocorticoid steroids always convey antiglucocorticoid activity?
    Lamontagne N; Mercier L; Pons M; Thompson EB; Simons SS
    Endocrinology; 1984 Jun; 114(6):2252-63. PubMed ID: 6547091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators.
    Chatterjee VK; Madison LD; Mayo S; Jameson JL
    Mol Endocrinol; 1991 Jan; 5(1):100-10. PubMed ID: 1708098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid receptor antagonists: new tools to investigate disorders characterized by cortisol hypersecretion.
    Peeters BW; Tonnaer JA; Groen MB; Broekkamp CL; van der Voort HA; Schoonen WG; Smets RJ; Vanderheyden PM; Gebhard R; Ruigt GS
    Stress; 2004 Dec; 7(4):233-41. PubMed ID: 16019588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.
    Schoch GA; D'Arcy B; Stihle M; Burger D; Bär D; Benz J; Thoma R; Ruf A
    J Mol Biol; 2010 Jan; 395(3):568-77. PubMed ID: 19913032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
    Peeters BW; Ruigt GS; Craighead M; Kitchener P
    Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression.
    Zhao Q; Pang J; Favata MF; Trzaskos JM
    Int Immunopharmacol; 2003 Dec; 3(13-14):1803-17. PubMed ID: 14636830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of mineralocorticoid and glucocorticoid receptors reverses stress-induced motor impairments.
    Jadavji NM; Supina RD; Metz GA
    Neuroendocrinology; 2011; 94(4):278-90. PubMed ID: 22024815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies.
    Lee S; Duncan KA; Chou H; Chen D; Kohli K; Huang CF; Stallcup MR
    Mol Endocrinol; 1995 Jul; 9(7):826-37. PubMed ID: 7476966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and activity of p-glycoprotein elevated by dexamethasone in cultured retinal pigment epithelium involve glucocorticoid receptor and pregnane X receptor.
    Zhang Y; Lu M; Sun X; Li C; Kuang X; Ruan X
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3508-15. PubMed ID: 22570346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism.
    McKay LI; Cidlowski JA
    Mol Endocrinol; 2000 Aug; 14(8):1222-34. PubMed ID: 10935546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids alter craniofacial development and increase expression and activity of matrix metalloproteinases in developing zebrafish (Danio rerio).
    Hillegass JM; Villano CM; Cooper KR; White LA
    Toxicol Sci; 2008 Apr; 102(2):413-24. PubMed ID: 18281261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the C terminus of the glucocorticoid receptor in hormone binding and agonist/antagonist discrimination.
    Zhang S; Liang X; Danielsen M
    Mol Endocrinol; 1996 Jan; 10(1):24-34. PubMed ID: 8838142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary expression of type I and type II glucocorticoid receptors during chicken embryonic development and their involvement in growth hormone cell differentiation.
    Bossis I; Nishimura S; Muchow M; Porter TE
    Endocrinology; 2004 Jul; 145(7):3523-31. PubMed ID: 15070856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenosides may reverse the dexamethasone-induced down-regulation of glucocorticoid receptor.
    Ling C; Li Y; Zhu X; Zhang C; Li M
    Gen Comp Endocrinol; 2005 Feb; 140(3):203-9. PubMed ID: 15639148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids.
    Pfeffer BA; DeWitt CA; Salvador-Silva M; Cavet ME; López FJ; Ward KW
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):437-46. PubMed ID: 19696178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic induction of apoptosis with glucocorticoids and 3',5'-cyclic adenosine monophosphate reveals agonist activity by RU 486.
    Gruol DJ; Altschmied J
    Mol Endocrinol; 1993 Jan; 7(1):104-13. PubMed ID: 8383286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.